3, 4, 5-Tricaffeoylquinic acid Catalog No.:M16772-C [O-]C(=O)CCNC1=CC(=NC(=N1)C1=CC=CC=N1)N1CCC2=CC=CC=C2CC1

[O-]C(=O)CCNC1=CC(=NC(=N1)C1=CC=CC=N1)N1CCC2=CC=CC=C2CC1

Mereletinib D6

but the final tumor volume does not differ significantly from the control

(2011) Blood

demonstrates robust in vivo efficacy in multiple models

3, 4, 5-Tricaffeoylquinic acid Catalog No.:M16772-C [O-]C(=O)CCNC1=CC(=NC(=N1)C1=CC=CC=N1)N1CCC2=CC=CC=C2CC13,4,5 Tricaffeoylquinic acid (3,4,5 triCQA) inhibits tumor necrosis factor stimulated production of inflammatory mediators in keratinocytes via suppression of Akt and NF B pathways. 3,4,5 Tricaffeoylquinic acid induces cell cycle arrest at G0 G1, actin cytoskeleton organization, chromatin remodeling, neuronal differentiation, and bone morphogenetic protein signaling in human neural stem cells. 3,4,5 Tricaffeoylquinic acid has the potential for the